[Problems of immunosuppressive therapy in human liver transplantation. I].
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D003920:Diabetes Mellitus / Q000139:chemically induced; D006087:Graft vs Host Reaction; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced; D016031:Liver Transplantation; D008297:Male; D009318:Natriuresis; D011188:Potassium / Q000097:blood / Q000652:urine; D011241:Prednisone / Q000008:administration & dosage; D012964:Sodium / Q000097:blood; D000637:Transaminases / Q000097:blood; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D001798:Blood Proteins; D007166:Immunosuppressive Agents; D012964:Sodium; D000637:Transaminases; D000469:Alkaline Phosphatase; D001379:Azathioprine; D001663:Bilirubin; D011188:Potassium; D011241:Prednisone
Die Probleme der immunosuppressiven Therapie bei der Humanlebertransplantation. I.